Zobrazeno 1 - 5
of 5
pro vyhledávání: '"G. Kh. Bagyeva"'
Autor:
S. N. Illarioshkin, P. A. Slominsky, M. I. Shadrina, G. Kh. Bagyeva, T. B. Zagorovskaya, E. D. Markova, A. V. Karabanov, V. V. Poleshchuk, E. V. Polevaya, N. V. Fedorova, S. A. Limborskaya, I. A. Ivanova-Smolenskaya
Publikováno v:
Анналы клинической и экспериментальной неврологии, Vol 1, Iss 1, Pp 23-31 (2007)
We performed search for mutations in the LRRK2, PRKN (parkin)and SNCA (a-synuclein) genes in 359 patients of Slavonic ethnicorigin (169 men and 190 women) with Parkinsons disease, ofwhom 345 represented sporadic cases. Age at the disease onset wasfro
Externí odkaz:
https://doaj.org/article/eea0e4fea6f94c35b934597007f0b95d
Autor:
Svetlana A. Limborska, Sergei N. Illarioshkin, G. Kh. Bagyeva, P. A. Slominsky, I. A. Ivanova-Smolenskaia, M. I. Shadrina, A. V. Karabanov, Elena V. Semenova
Publikováno v:
Russian Journal of Genetics. 45:504-506
Fifty-two patients that had Parkinson’s disease with autosomal dominant type of inheritance were analyzed for the presence of duplications and triplications in exons 4–6 of α-synuclein gene using real-time PCR with TaqMan probes. No mutations in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::608f35f597595e568b95ce17d74a50ea
https://doi.org/10.1134/s1022795409040176
https://doi.org/10.1134/s1022795409040176
Autor:
T N, Fedorova, G Kh, Bagyeva, I S, Dobrotvorskaia, M S, Stepanova, E V, Polevaia, I A, Ivanova-Smolenskaia, S N, Illarioshkin
Publikováno v:
Eksperimental'naia i klinicheskaia farmakologiia. 75(6)
The efficiency of mexidant therapy in patients with Parkinson's disease (PD) has been evaluated. The study included 49 patients aged 58-65 with a trembling-rigid and trembling forms of PD at an disease duration of 6.5 +/- 3.8 years. All patients were
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0176e095f4de5ec9ec00181b98ca63db
https://pubmed.ncbi.nlm.nih.gov/22891437
https://pubmed.ncbi.nlm.nih.gov/22891437
Autor:
G. Kh. Bagyeva, Maria Shadrina, Markova Ed, T. B. Zagorovskaya, E. V. Bespalova, Irina A. Ivanova-Smolenskaya, Petr Slominsky, Svetlana A. Limborska, Sergey N. Illarioshkin
Publikováno v:
European journal of neurology. 14(4)
A PARK8 form of Parkinson's disease (PD) is caused by a novel gene, leucine-rich repeat kinase 2 (LRRK2), and a single mutation G2019S was found in a proportion of LRRK2-associated cases of diverse ethnic origins. We performed the LRRK2 G2019S mutati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f4b6aa3e52c47bfc0ebc5cccbba2b705
https://pubmed.ncbi.nlm.nih.gov/17388990
https://pubmed.ncbi.nlm.nih.gov/17388990
Autor:
S N, Illarioshkin, I A, Ivanova-Smolenskaia, T B, Zagorovskaia, A V, Karabanov, V V, Poleshchuk, E D, Markova, E A, Karpova, E V, Polevaia, G Kh, Bagyeva, S L, Timerbaeva, Sh A, Nurmanova
Publikováno v:
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 106(11)
The results of mirapex (pramipexol) treatment of 402 patients with Parkinson's disease and juvenile parkinsonism during the period from 6 months to 7 years are summarized. Mirapex was used in monotherapy as well as in combination with levadopa and ot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6e3eff07588c2a6e89dffb5fbc24fb67
https://pubmed.ncbi.nlm.nih.gov/17180757
https://pubmed.ncbi.nlm.nih.gov/17180757